HomeQuestion

How do you choose between using inebilizumab and rituximab for patients with NMOSD?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

What criteria do you use to differentiate between MOGAD and MS in pediatric patients?

Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?

In a patient with prior biopsy-proven IgG4-related pachymeningitis who develops recurrent neurologic symptoms years after discontinuing immunosuppression, how do you determine whether this represents relapse versus alternative etiologies?

When would you obtain optic nerve testing in patients suspected to have multiple sclerosis without a clinical history of optic neuritis?

How do you counsel patients interested in primary prevention of MS?

Evidence Meets Expertise

For Physicians

Mednet AI
Community

Company

About
Careers
Publications
Blog

Support

FAQs
Code of Conduct
AI Community Guidelines
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.